Last quarter (Q2 2025), Medicenna Therapeutics Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Medicenna Therapeutics Corp's net income was $-4.16M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 18.34M	$ 18.67M	$ 16.30M	$ 27.38M	$ 17.39M	$ 8.24M
Operating Income	$ -18.34M	$ -18.67M	$ -16.30M	$ -27.38M	$ -17.39M	$ -8.24M
Net Non Operating Interest Income Expense	$ 1.22M	$ 1.20M	$ 262.00K	$ 69.00K	$ -314.00K	$ -7.00K
Other Income Expense	$ 9.41M	$ 7.92M	$ -4.35M	$ ―	$ -208.00K	$ -39.00K
Pretax Income	$ -26.68M	$ -25.47M	$ -10.05M	$ -27.14M	$ -17.29M	$ -8.28M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -26.68M	$ -25.47M	$ -10.05M	$ -27.14M	$ -17.29M	$ -8.28M
Basic EPS	$ -0.37	$ -0.37	$ -0.16	$ -0.42	$ -0.35	$ -0.26
Diluted EPS	$ -0.37	$ -0.37	$ -0.16	$ -0.42	$ -0.35	$ -0.26
Basic Average Shares	$ 289.74M	$ 69.64M	$ 64.74M	$ 54.29M	$ 49.66M	$ 31.90M
Diluted Average Shares	$ 289.74M	$ 69.64M	$ 64.74M	$ 54.29M	$ 49.66M	$ 31.90M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 18.34M	$ 18.67M	$ ―	$ ―	$ -17.39M	$ -8.24M
Net Income From Continuing And Discontinued Operation	$ -26.68M	$ -25.47M	$ -10.05M	$ -27.14M	$ -17.29M	$ -8.28M
Normalized Income	$ -21.60M	$ -18.72M	$ -7.39M	$ -19.95M	$ -12.71M	$ -6.08M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -26.68M	$ -25.47M	$ -16.30M	$ -27.14M	$ -17.29M	$ -8.28M
EBITDA	$ -26.66M	$ -25.46M	$ -16.30M	$ -27.10M	$ -17.25M	$ -8.27M

Currency in USD

Medicenna Therapeutics Corp Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing